TY - JOUR
T1 - The Pediatric Anxiety Rating Scale (PARS)
T2 - Development and Psychometric Properties
AU - Riddle,
N1 - Funding Information:
Supported by contracts from the NIMH to Johns Hopkins University ( N01MH60016 ; PI: Dr. Riddle) and the Research Foundation for Mental Hygiene ( N01MH60005 ; PI: Dr. Greenhill) and Solvay Pharmaceuticals; NIMH grants MH57503 and MH-01391 (Dr. Pine); NIMH RUPP contract N01MH70010 (Dr. McCracken); and National Center for Research Resources/NIH General Clinical Research Center grant M01 RR00052 (Johns Hopkins University School of Medicine).
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2002/9
Y1 - 2002/9
N2 - Objective: To describe the development and psychometric properties of the Pediatric Anxiety Rating Scale (PARS), a clinician-rated instrument for assessing the severity of anxiety symptoms associated with common DSM-IV anxiety disorders (social phobia, separation anxiety disorder, and generalized anxiety disorder) in children. Method: As part of a multisite study of the efficacy of fluvoxamine, 128 children (aged 6-17) and their parents were interviewed weekly with the PARS. Data from multiple raters on a subsample of children (using live and videotaped interviews) were used to evaluate interrater reliability. Internal consistency, test-retest reliability, and validity (convergent, divergent) also were evaluated. Results: The PARS showed high interrater reliability, adequate test-retest reliability, and fair internal consistency. Convergent and divergent validity were satisfactory. PARS scores were sensitive to treatment and paralleled change in other measures of anxiety symptoms and global improvement. Conclusions: The PARS is a useful clinician-rated instrument for assessing pediatric anxiety symptoms, severity, and impairment, particularly in treatment studies. Further study of the psychometric properties is warranted.
AB - Objective: To describe the development and psychometric properties of the Pediatric Anxiety Rating Scale (PARS), a clinician-rated instrument for assessing the severity of anxiety symptoms associated with common DSM-IV anxiety disorders (social phobia, separation anxiety disorder, and generalized anxiety disorder) in children. Method: As part of a multisite study of the efficacy of fluvoxamine, 128 children (aged 6-17) and their parents were interviewed weekly with the PARS. Data from multiple raters on a subsample of children (using live and videotaped interviews) were used to evaluate interrater reliability. Internal consistency, test-retest reliability, and validity (convergent, divergent) also were evaluated. Results: The PARS showed high interrater reliability, adequate test-retest reliability, and fair internal consistency. Convergent and divergent validity were satisfactory. PARS scores were sensitive to treatment and paralleled change in other measures of anxiety symptoms and global improvement. Conclusions: The PARS is a useful clinician-rated instrument for assessing pediatric anxiety symptoms, severity, and impairment, particularly in treatment studies. Further study of the psychometric properties is warranted.
KW - Adolescents
KW - Anxiety
KW - Assessment
KW - Children
KW - Rating scales
UR - http://www.scopus.com/inward/record.url?scp=0036718715&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036718715&partnerID=8YFLogxK
U2 - 10.1097/00004583-200209000-00006
DO - 10.1097/00004583-200209000-00006
M3 - Article
C2 - 12218427
AN - SCOPUS:0036718715
SN - 0890-8567
VL - 41
SP - 1061
EP - 1069
JO - Journal of the American Academy of Child and Adolescent Psychiatry
JF - Journal of the American Academy of Child and Adolescent Psychiatry
IS - 9
ER -